EUVIMEDEUVIMED entdecken
Crossref

Pathogenic POLE-Mutated Endometrial Carcinomas With a Nonultramutated Genome

Shruti Srikumar, Nick Evans, Melissa Yuwono Tjota, Mir Alikhan, Amandeep Kaur, Linda M Sabatini, Nick Miller, Mike Bouma, Kruti P Maniar, Megan Parilla

Modern Pathology · 2026-02 · 39 (2) · 100946

DOI: 10.1016/j.modpat.2025.100946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026-02. Verfasst von Shruti Srikumar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, NorthShore Hospital, Evanston, Illinois. Hauptthemen laut MEDLINE: Endometrial Neoplasms, DNA Polymerase II, Poly-ADP-Ribose Binding Proteins, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NorthShore University HealthSystem.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial carcinomas can be classified into 1 of 4 molecular subtypes, with the POLE-mutant subtype carrying the best prognosis. Pathogenic mutations in POLE are known to disrupt the proofreading function of DNA polymerase epsilon, resulting in an ultramutated genome, typically defined as ≥100 mutations per megabase. Routine next-generation sequencing was implemented on all endometrial carcinoma cases at our institution beginning in December 2023 to aid in molecular subclassification. During this routine sequencing, 6 POLE-mutated cases, with confirmed pathogenic POLE mutations, were observed to have a tumor mutational burden

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsDNA Polymerase IIPoly-ADP-Ribose Binding ProteinsMutationBiomarkers, TumorHumansFemaleMiddle AgedAgedAged, 80 and overHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

POLEendometrial carcinomastumor mutation burdenultramutated

Substanzen

DNA Polymerase IIPOLE protein, humanPoly-ADP-Ribose Binding ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, NorthShore Hospital, Evanston, Illinois.
  • Mark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, Illinois.
  • Department of Pathology, The University of Chicago, Chicago, Illinois.
  • Department of Pathology, NorthShore Hospital, Evanston, Illinois. Electronic address: MParilla@northshore.org.

Förderung

  • NorthShore University HealthSystem

Zitieren

APA

Srikumar, S., Evans, N., Tjota, M. Y., Alikhan, M., Kaur, A., Sabatini, L. M., Miller, N., Bouma, M., Maniar, K. P., & Parilla, M. (2026). Pathogenic POLE-Mutated Endometrial Carcinomas With a Nonultramutated Genome. Modern Pathology, 39(2), 100946. https://doi.org/10.1016/j.modpat.2025.100946

Vancouver

Srikumar S, Evans N, Tjota MY, Alikhan M, Kaur A, Sabatini LM, et al. Pathogenic POLE-Mutated Endometrial Carcinomas With a Nonultramutated Genome. Modern Pathology. 2026;39(2):100946. doi:10.1016/j.modpat.2025.100946

BibTeX
@article{Srikumar2026,
  author = {Srikumar, Shruti and Evans, Nick and Tjota, Melissa Yuwono and Alikhan, Mir and Kaur, Amandeep and Sabatini, Linda M and Miller, Nick and Bouma, Mike and Maniar, Kruti P and Parilla, Megan},
  title = {Pathogenic POLE-Mutated Endometrial Carcinomas With a Nonultramutated Genome},
  journal = {Modern Pathology},
  year = {2026},
  volume = {39},
  number = {2},
  pages = {100946},
  doi = {10.1016/j.modpat.2025.100946}
}
Kostenlos starten →